Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Osteotech, a provider of biologic solutions for regenerative healing, has received 510(k) clearance from the FDA for its next generation grafting material.
Subscribe to our email newsletter
Osteotech has received 510(k) clearance for this material as a bone graft substitute, and as a bone void filler, for use in the spine, pelvis and extremities.
Sam Owusu-Akyaw, president and CEO of Osteotech, said: “Receiving FDA clearance for our next generation grafting material is a great accomplishment for our team and another key milestone in our strategic plan.”